Castleman's Disease
8 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| A Cohort Study of Plasma Cell Disorders (PCDs) in PKUFH (NCT05283993) | Peking University First Hospital | 2021-07-01 |
| Registry for Adults With Plasma Cell Disorders (PCD's) (NCT03717844) | UNC Lineberger Comprehensive Cancer Center | 2018-02-09 |
| Molecular Characterization of Viral-associated Tumors, Tumors Occurring in the Setting of HIV or Other Immune Disorders and Castleman Disease (NCT03300830) | National Cancer Institute (NCI) | 2017-12-20 |
| International Registry for Patients With Castleman Disease (NCT02817997) | University of Pennsylvania | 2016-10-01 |
| Unlock the Cell: Castleman's Disease Flow Cytometry Study (NCT02853968) | University of Pennsylvania | 2016-02-01 |
| Dose-escalation Study of Oral CX-4945 (NCT00891280) | Cylene Pharmaceuticals | 2009-02-01 |
| A Study to Provide RoActemra/Actemra (Tocilzumab) to Patients With Multicentric Castleman's Disease Who Demonstrated Benefit From Previous RoActemra/Actemra Treatment (NCT01183598) | Hoffmann-La Roche | 2006-08-01 |
Track Castleman's Disease automatically
Every clearance here is in the API, with alerts when new ones post.